Devicare

About:

Devicare is a biotech company developing medical treatments in Urology by combining innovative therapies with digital technologies

Website: http://www.devicare.com/

Twitter/X: devicare

Top Investors: ICF Capital, Peroxfarma, Ona Capital Privat SCR SA, Ship2B, Avançsa

Description:

Devicare is a specialty biotech company dedicated to developing groundbreaking medical treatments in Urology by combining innovative therapies with digital technologies. Devicare is dedicated to improving and easing the lives of patients who suffer from urological diseases and disorders. Devicare's vision is to be a ground-breaking leader in urology with innovative medical treatments, patent protected, clinically-proven and patient-centric.

Total Funding Amount:

$11.6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Barcelona, Catalonia, Spain

Founded Date:

2012-01-01

Contact Email:

info(AT)devicare.com

Founders:

Rosendo Garganta

Number of Employees:

11-50

Last Funding Date:

2021-01-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai